(D-Lys(nicotinoyl)1,β-(3-pyridyl)-Ala3,3,4-dichloro-D-Phe5,Asn6,D-Trp7·9,Nle11)-Substance P trifluoroacetate salt structure
|
Common Name | (D-Lys(nicotinoyl)1,β-(3-pyridyl)-Ala3,3,4-dichloro-D-Phe5,Asn6,D-Trp7·9,Nle11)-Substance P trifluoroacetate salt | ||
---|---|---|---|---|
CAS Number | 129176-97-2 | Molecular Weight | 1668.79 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C86H104Cl2N18O13 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of (D-Lys(nicotinoyl)1,β-(3-pyridyl)-Ala3,3,4-dichloro-D-Phe5,Asn6,D-Trp7·9,Nle11)-Substance P trifluoroacetate saltSpantide II, an undecapeptide substance P (SP) analog, is a potent neurokinin-1 receptor (NK-1R) antagonist. Spantide II binds with NK-1R and blocks proinflammatory activities associated with SP. Spantide II can be used in the research of inflammatory skin disorders, such as psoriasis and contact dermatitis[1][2][3]. |
Name | spantide II |
---|
Description | Spantide II, an undecapeptide substance P (SP) analog, is a potent neurokinin-1 receptor (NK-1R) antagonist. Spantide II binds with NK-1R and blocks proinflammatory activities associated with SP. Spantide II can be used in the research of inflammatory skin disorders, such as psoriasis and contact dermatitis[1][2][3]. |
---|---|
Related Catalog | |
Target |
NK1 |
References |
Molecular Formula | C86H104Cl2N18O13 |
---|---|
Molecular Weight | 1668.79 |